CCL2 was measured at very low levels (<10 pg/mL) by enzyme-linked immunosorbent assays (ELISA) in prostate cancer cell supernatants and U-937 supernatants (147.5 ± 24 pg/mL)(Figure 3A). This evidence concerns the gene CCL2 and Familial prostate cancer.